Orly Vardeny

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. doi request reprint β-AR polymorphisms and glycemic and lipid parameters in hypertensive individuals receiving carvedilol or metoprolol
    Orly Vardeny
    University of Wisconsin School of Pharmacy, Madison, WI, USA
    Am J Hypertens 25:920-6. 2012
  2. doi request reprint Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study)
    Orly Vardeny
    University of Wisconsin School of Pharmacy, Madison, WI, USA
    J Am Coll Cardiol 60:2082-9. 2012
  3. doi request reprint Influence of diabetes on efficacy of aliskiren, losartan or both on left ventricular mass regression
    Orly Vardeny
    University of Wisconsin School of Pharmacy, Madison, WI 53705 2222, USA
    J Renin Angiotensin Aldosterone Syst 13:265-72. 2012
  4. pmc Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease
    Orly Vardeny
    University of Wisconsin School of Pharmacy, Madison, Wisconsin, USA
    Am J Cardiol 107:1705-9. 2011
  5. pmc The beta2 adrenergic receptor Gln27Glu polymorphism affects insulin resistance in patients with heart failure: possible modulation by choice of beta blocker
    Orly Vardeny
    University of Wisconsin School of Pharmacy, Pharmacy Practice Division, Madison, WI 53705 2222, USA
    J Cardiovasc Pharmacol 52:500-6. 2008
  6. pmc Decreased immune responses to influenza vaccination in patients with heart failure
    Orly Vardeny
    University of Wisconsin School of Pharmacy, Madison, Wisconsin 53705 2222, USA
    J Card Fail 15:368-73. 2009
  7. pmc β2 adrenergic receptor polymorphisms and nocturnal blood pressure dipping status in the Wisconsin Sleep Cohort Study
    Orly Vardeny
    University of Wisconsin School of Pharmacy, Madison, Wisconsin 53705 2222, USA
    J Am Soc Hypertens 5:114-22. 2011
  8. pmc Double dose vs. standard dose influenza vaccination in patients with heart failure: a pilot study
    Amy Van Ermen
    School of Pharmacy, University of Wisconsin, Madison, WI 53705, USA
    Eur J Heart Fail 15:560-4. 2013
  9. doi request reprint Race influences the safety and efficacy of spironolactone in severe heart failure
    Orly Vardeny
    University of Wisconsin School of Pharmacy, Madison, WI
    Circ Heart Fail 6:970-6. 2013
  10. doi request reprint Decreased T-cell responses to influenza vaccination in patients with heart failure
    Orly Vardeny
    University of Wisconsin, Madison, 53705 2222, USA
    Pharmacotherapy 30:10-6. 2010

Detail Information

Publications12

  1. doi request reprint β-AR polymorphisms and glycemic and lipid parameters in hypertensive individuals receiving carvedilol or metoprolol
    Orly Vardeny
    University of Wisconsin School of Pharmacy, Madison, WI, USA
    Am J Hypertens 25:920-6. 2012
    ..We investigated associations of common β1 and β2-AR single-nucleotide polymorphisms (SNPs) with metabolic and lipid variables, and examined interactions with β-blocker treatment assignment to affect these parameters...
  2. doi request reprint Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study)
    Orly Vardeny
    University of Wisconsin School of Pharmacy, Madison, WI, USA
    J Am Coll Cardiol 60:2082-9. 2012
    ..This study investigated the influence of baseline and worsening renal function (WRF) on the efficacy of spironolactone in patients with severe heart failure (HF)...
  3. doi request reprint Influence of diabetes on efficacy of aliskiren, losartan or both on left ventricular mass regression
    Orly Vardeny
    University of Wisconsin School of Pharmacy, Madison, WI 53705 2222, USA
    J Renin Angiotensin Aldosterone Syst 13:265-72. 2012
    ....
  4. pmc Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease
    Orly Vardeny
    University of Wisconsin School of Pharmacy, Madison, Wisconsin, USA
    Am J Cardiol 107:1705-9. 2011
    ..In conclusion, these data suggest that ACE inhibition may attenuate the risk for glucose abnormalities observed in patients taking β blockers...
  5. pmc The beta2 adrenergic receptor Gln27Glu polymorphism affects insulin resistance in patients with heart failure: possible modulation by choice of beta blocker
    Orly Vardeny
    University of Wisconsin School of Pharmacy, Pharmacy Practice Division, Madison, WI 53705 2222, USA
    J Cardiovasc Pharmacol 52:500-6. 2008
    ..Future studies are needed to confirm whether treatment with carvedilol may be associated with decreased insulin and insulin resistance in beta2-AR codon 27 Gln carriers...
  6. pmc Decreased immune responses to influenza vaccination in patients with heart failure
    Orly Vardeny
    University of Wisconsin School of Pharmacy, Madison, Wisconsin 53705 2222, USA
    J Card Fail 15:368-73. 2009
    ..Both humoral (antibody) and cytotoxic T-lymphocyte (CTL) responses are important for protection. We explored antibody- and CTL-mediated responses to the influenza vaccine in HF patients compared with healthy controls...
  7. pmc β2 adrenergic receptor polymorphisms and nocturnal blood pressure dipping status in the Wisconsin Sleep Cohort Study
    Orly Vardeny
    University of Wisconsin School of Pharmacy, Madison, Wisconsin 53705 2222, USA
    J Am Soc Hypertens 5:114-22. 2011
    ..Higher dipping ratios indicating a lack of nocturnal BP dipping are associated with β2-AR polymorphisms. Nocturnal dipping patterns may be modulated by β2-AR polymorphisms...
  8. pmc Double dose vs. standard dose influenza vaccination in patients with heart failure: a pilot study
    Amy Van Ermen
    School of Pharmacy, University of Wisconsin, Madison, WI 53705, USA
    Eur J Heart Fail 15:560-4. 2013
    ..We hypothesized that patients with heart failure randomized to double dose (DD) influenza vaccine will mount more vigorous humoral immune responses compared with those given standard dose (SD) vaccine...
  9. doi request reprint Race influences the safety and efficacy of spironolactone in severe heart failure
    Orly Vardeny
    University of Wisconsin School of Pharmacy, Madison, WI
    Circ Heart Fail 6:970-6. 2013
    ..The incidence of hyperkalemia caused by mineralocorticoid receptor antagonists may vary by race, but whether race influences efficacy of mineralocorticoid receptor antagonists in heart failure (HF) is unknown...
  10. doi request reprint Decreased T-cell responses to influenza vaccination in patients with heart failure
    Orly Vardeny
    University of Wisconsin, Madison, 53705 2222, USA
    Pharmacotherapy 30:10-6. 2010
    ..To determine whether T-cell immune responses to influenza vaccination in patients with chronic heart failure (CHF) are less vigorous than the responses of healthy control subjects...
  11. pmc Pharmacy students' retention of knowledge and skills following training in automated external defibrillator use
    Karen Birckelbaw Kopacek
    University of Wisconsin School of Pharmacy, Madison, Wisconsin 53705, USA
    Am J Pharm Educ 74:109. 2010
    ..To assess pharmacy students' retention of knowledge about appropriate automated external defibrillator use and counseling points following didactic training and simulated experience...
  12. doi request reprint Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk
    Orly Vardeny
    School of Pharmacy, University of Wisconsin, 777 Highland Avenue, Madison, WI 53705 2222, USA
    Cardiol Clin 26:589-601. 2008
    ....